tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market
Advertisement

Biogen (BIIB) Technical Analysis

Compare
4,844 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is 0.51, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 130.30, while Biogen’s (BIIB) share price is $128.69, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 129.53, while Biogen’s (BIIB) share price is $128.69, making it a Sell.

Biogen (BIIB) Pivot Points

Jul 19, 2025, 12:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
125.33
126.37
127.42
128.46
129.51
130.55
131.60
Fibonacci
126.37
127.17
127.66
128.46
129.26
129.75
130.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Jul 19, 2025, 12:25 AM
Period
Simple
Exponential
MA5
130.39Sell
129.86Sell
MA10
131.78Sell
130.51Sell
MA20
129.58Sell
130.30Sell
MA50
128.37Buy
129.53Sell
MA100
130.01Sell
133.38Sell
MA200
145.34Sell
150.41Sell
Biogen’s (BIIB) 10-Day exponential moving average is 130.51, while Biogen’s (BIIB) share price is $128.69, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 133.38, while Biogen’s (BIIB) share price is $128.69, making it a Sell.
Biogen’s (BIIB) stock price is $128.69 and Biogen’s (BIIB) 50-day simple moving average is 128.37, creating a Buy signal.
Biogen’s (BIIB) stock price is $128.69 and Biogen’s (BIIB) 100-day simple moving average is 130.01, creating a Sell signal.
Biogen’s (BIIB) stock price is $128.69 and Biogen’s (BIIB) 200-day simple moving average is 145.34, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Jul 19, 2025, 12:25 AM
Name
Value
Implied Action
RSI (14)
47.36
Neutral
STOCH (9,6)
7.79
Buy
STOCHRSI (14)
30.97
Neutral
MACD (12,26)
0.51
Buy
ADX (14)
14.46
Buy
Williams %R
-65.64
Buy
CCI (14)
-30.10
Neutral
ATR (14)
3.65
-
Ultimate Oscillator
39.23
Neutral
ROC
1.39
Buy
Biogen’s (BIIB) Relative Strength Index (RSI) is 47.36, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 14.46, creating a Buy signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -30.10, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is 1.39, creating a Buy signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 47.36, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is 0.51, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 130.39, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 129.58, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 128.37, which suggests BIIB is a Buy.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 145.34, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -65.64, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -30.10, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis